Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      Cepheid Announces WHO Prequalification Of Xpert HIV-1 Qualitative Test

      Americas
      Cepheid announced that its Xpert® HIV-1 Qual test has been awarded WHO prequalification, making it one of the first molecular point of care tests...

      FDA Panel To Review the Amgen’s ABP 501, Biosimilar Candidate To Adalimumab

      Americas
      Amgen announced that the Arthritis Advisory Committee of the U.S. FDA will review data supporting the Company's Biologics License Application (BLA) for ABP 501,...

      Eisai presents data on its anti-fractalkine monoclonal antibody E6011

      Americas
      Eisai Co Ltd. announced that interim analyses on the latest data for the world's first anti-fractalkine monoclonal antibody E6011, discovered by Eisai's research subsidiary...

      Merck, Pfizer double size of diabetes study to catch rivals

      Americas
      Merck in partnership with Pfizer Inc. announced that two Phase 3 studies (VERTIS Mono and VERTIS Factorial) of ertugliflozin, an investigational oral SGLT-2 inhibitor...

      Dr Reddy’s drops as US agency charges firm for packaging lapses

      Americas
      The US CPSC, which is tasked with protecting children and families from risks of injuries or death associated with consumer products, had taken issue...

      Biogen tanks as opicinumab misses Phase II endpoints in MS trial

      Americas
      Biogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being developed as a potential...

      Pharma Giant Eli Lilly Wants to Launch 20 New Drugs by 2023

      Americas
      Indianapolis-based pharmaceutical giant Eli Lilly LLY -0.64% laid out an ambitious R&D agenda for launching up to 20 new drugs by 2023 during an...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.